To further elucidate the pivotal role of PLA2G16 in the management of pancreatic cancer, clinical and gene-expression data from TCGA were utilized, totaling 102 primary tumor samples who underwent gemcitabine treatment. The gene discussed is PLAAT3; the disease is familial pancreatic carcinoma.